Cargando…

Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461136/
https://www.ncbi.nlm.nih.gov/pubmed/26082656
http://dx.doi.org/10.2147/CCID.S88448
_version_ 1782375488269844480
collection PubMed
description
format Online
Article
Text
id pubmed-4461136
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44611362015-06-16 Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] Clin Cosmet Investig Dermatol Corrigendum Dove Medical Press 2015-06-05 /pmc/articles/PMC4461136/ /pubmed/26082656 http://dx.doi.org/10.2147/CCID.S88448 Text en © 2015 Menon and David. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Corrigendum
Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
title Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
title_full Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
title_fullStr Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
title_full_unstemmed Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
title_short Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
title_sort itolizumab – a humanized anti-cd6 monoclonal antibody with better side effects profile for the treatment of psoriasis [corrigendum]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461136/
https://www.ncbi.nlm.nih.gov/pubmed/26082656
http://dx.doi.org/10.2147/CCID.S88448